Editorial
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy
Journal of Gastrointestinal Oncology
2016;
7
(1)
:1-2
.
(01 February 2016)
Original Article
Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Journal of Gastrointestinal Oncology
2016;
7
(1)
:3-9
.
(01 February 2016)
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?
Journal of Gastrointestinal Oncology
2016;
7
(1)
:10-17
.
(01 February 2016)
Review Article
Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective
Journal of Gastrointestinal Oncology
2016;
7
(1)
:18-28
.
(01 February 2016)
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy
Journal of Gastrointestinal Oncology
2016;
7
(1)
:29-44
.
(01 February 2016)
Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy
Journal of Gastrointestinal Oncology
2016;
7
(1)
:45-57
.
(01 February 2016)
Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
Journal of Gastrointestinal Oncology
2016;
7
(1)
:58-71
.
(01 February 2016)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection
Journal of Gastrointestinal Oncology
2016;
7
(1)
:72-78
.
(01 February 2016)
Diagnosis and management of patients with malignant peritoneal mesothelioma
Journal of Gastrointestinal Oncology
2016;
7
(1)
:79-86
.
(01 February 2016)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?
Journal of Gastrointestinal Oncology
2016;
7
(1)
:87-98
.
(01 February 2016)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality
Journal of Gastrointestinal Oncology
2016;
7
(1)
:99-111
.
(01 February 2016)
Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?
Journal of Gastrointestinal Oncology
2016;
7
(1)
:112-121
.
(01 February 2016)
Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion
Journal of Gastrointestinal Oncology
2016;
7
(1)
:122-128
.
(01 February 2016)
Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes
Journal of Gastrointestinal Oncology
2016;
7
(1)
:129-142
.
(01 February 2016)
Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future
Journal of Gastrointestinal Oncology
2016;
7
(1)
:143-157
.
(01 February 2016)
Disclosure:
The focused issue “Cytoreductive Surgery and HIPEC” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Giorgos C. Karakousis and H. Richard Alexander served as the unpaid Guest Editors for the focused issue.
